Innovative Research Award
Thomas Vogl is a German academic researcher affiliated with Klinikum der Goethe-Universität whose scholarly work has contributed extensively to medical imaging, interventional radiology, and breast cancer research. His publication record, citation impact, and sustained scientific productivity demonstrate an influential research career recognized through international indexing databases.[1]
Abstract
Thomas Vogl has established an internationally recognized academic profile through extensive research in breast cancer imaging, interventional radiology, image-guided therapies, and minimally invasive treatment strategies. His scientific publications have significantly contributed to advances in diagnostic accuracy, clinical decision-making, and therapeutic innovation. According to indexed scholarly databases, his research output exceeds one thousand publications with substantial citation impact and a high h-index, reflecting sustained influence across medical science. These accomplishments demonstrate continued commitment to evidence-based healthcare, interdisciplinary collaboration, and scientific excellence, supporting recognition through the Cryogenicist Global Awards for innovative research achievements.[1]
Keywords
Breast Cancer, Interventional Radiology, Medical Imaging, MRI, Image-Guided Therapy, Clinical Research, Oncology, Minimally Invasive Treatment, Scientific Publications, Academic Excellence.
Introduction
Breast cancer research increasingly relies on advanced imaging technologies and minimally invasive therapeutic approaches to improve diagnosis and patient outcomes. Thomas Vogl has contributed to these developments through multidisciplinary investigations integrating radiological innovation with clinical oncology while supporting evidence-based healthcare practices.[2]
Research Profile
The research profile of Thomas Vogl reflects extensive scholarly productivity documented by Scopus, including more than 1,400 indexed publications, over 57,000 citations, and an h-index of 116. These metrics indicate sustained academic influence across radiology, oncology, and translational medical research.[1]
Research Contributions
His investigations have explored diagnostic imaging, magnetic resonance imaging, image-guided interventions, tumor ablation, and treatment optimization for breast cancer and related diseases. These studies have contributed valuable clinical evidence supporting improved diagnostic precision and therapeutic planning across multidisciplinary healthcare environments.[3]
Publications
Thomas Vogl has authored numerous peer-reviewed journal articles, reviews, and collaborative studies published in internationally recognized medical journals. His publication portfolio demonstrates consistent engagement with high-quality clinical research and broad collaboration across academic institutions and healthcare organizations worldwide.[4]
Research Impact
The substantial citation record associated with Thomas Vogl illustrates the continuing relevance of his scientific contributions within radiology and oncology communities. His work has informed subsequent investigations, clinical guidelines, and evidence-based practices while supporting innovation in medical imaging and patient-centered treatment strategies.[5]
Award Suitability
Considering his sustained publication record, measurable scholarly influence, international collaboration, and continued advancement of imaging technologies relevant to cancer management, Thomas Vogl represents a strong candidate for recognition within the Innovative Research Award category of the Cryogenicist Global Awards based on documented academic achievements.[1]
Conclusion
Thomas Vogl’s academic career demonstrates sustained contributions to breast cancer imaging and interventional radiology through influential research, extensive publication activity, and internationally recognized scholarly impact. His documented achievements provide a strong academic foundation for consideration within research recognition programs emphasizing innovation and scientific excellence.[1]
External Links
References
- Elsevier. (n.d.). Scopus author details: Thomas Vogl, Author ID 35444602000. Scopus.
https://www.scopus.com/authid/detail.uri?authorId=35444602000
- World Health Organization. Breast Cancer Fact Sheet.
https://www.who.int/news-room/fact-sheets/detail/breast-cancer
- Catania, T., Morabito, G., Barbera, S., Venturini, M., Fontana, F., Maccarrone, E., Arillotta, G. M., Ascenti, V., Mazziotti, S., Vogl, T. J., Foti, G., D’Angelo, T., & Ascenti, G. (2026). Differentiation of adrenal adenomas from non-adenomatous lesions: Diagnostic value of unenhanced spectral CT. Tomography, 12(5), 68.
https://doi.org/10.3390/tomography12050068
- Gruenewald, L. D., Mansouri, S., Booz, C., Gotta, J., Reschke, P., D’Angelo, T., Alrahmoun, M., Mahmoudi, S., Martin, S. S., … & Koch, V. (2026). Gravitational 3D magnetic resonance elastography for differentiating focal nodular hyperplasia and hepatic adenoma. Diagnostics, 16(10), 1569.
https://doi.org/10.3390/diagnostics16101569
- Roy, D., Oppermann, E., Vogl, T. J., Büdeyri, I., Shapiro, D., Struecker, B., Rolfo, C. D., Abedin, N., Zharov, V. P., Schnitzbauer, A., Pascher, A., Bechstein, W. O., Zimmermann, M. S., & Juratli, M. A. (2025). The prognostic value of circulating stem cells expressing PD-L1 in patients with hepatocellular carcinoma. Journal of Hepatocellular Carcinoma. Advance online publication.
https://doi.org/10.2147/JHC.S598753